Seventure Partners racks up about $176 mln for microbiome fund
Seventure Partners has raised 160 million euros (about $176 million) for its microbiome-focused Health for Life Capital fund. Novartis Pharma AG recently joined the fund's investor base. Health for Life Capital's other backers include Danone, Tereos, Lesaffre, Bel, Tornier and the Danish Technology Institute. Since launching in December 2013, the fund has made undisclosed investments in a number of companies that include Enterome, LNC, Maat pharma, Eligo bioscience, Targedys and Micropharma.
14 December 2015•4 mins read
